Regeneron CEO Leonard Schleifer in Boston: drug pricing could be 'the undoing of our industry' - Boston Business Journal
Regeneron CEO Takes Industry Counterview On FTC News: “I'm Glad They're Looking Into This” :: Scrip
George Yancopoulos and Leonard Schleifer
Q&A: Regeneron Founder – and UVA M.D./Ph.D. Alum – Discusses COVID-19 Treatment | UVA Today
SPOTLIGHT! HARRIET AND LEONARD SCHLEIFER | Jewish Federation of Greater New Haven
Len Schleifer and George Yancopoulos | Cold Spring Harbor Laboratory
Leonard S. Schleifer, M.D. and PhD
With $453M, Regeneron's Schleifer tops biopharma's realized pay
Leonard Schleifer - Society for Science
Chapel Haven Schleifer Center, Inc. opens new chapter! – Chapel Haven
Watch CNBC's full interview with Regeneron CEO Len Schleifer - YouTube
Without equity awards, Regeneron's Schleifer made $7M in 2022
Regeneron Is Replacing Intel as Sponsor of Science Talent Search | Fortune
Chinese food, Italian food and mice: The genius of Regeneron
Regeneron boss backs attempt to block $28bn Amgen acquisition | Financial Times
Regeneron CEO Schleifer, chief scientist Yancopoulos bag massive $270M payday | Fierce Pharma
Leonard S. Schleifer, MD, PhD – UVA Medical Alumni Association
Meet the Queens-bred billionaires behind COVID drug-maker Regeneron
Regeneron CEO: Trump's Use of Drug 'Weakest Evidence' of Any Success
Regeneron CEO: Trump 'is a case of one' and 'weakest evidence' for Covid-19 treatment - POLITICO
Regeneron CEO says "halo effect" of New York funding competition is good for business - Albany Business Review
4. Leonard Schleifer, Regeneron Pharmaceuticals | | santamariatimes.com
Leonard Schleifer - Society for Science
Transcript: Regeneron CEO Leonard Schleifer on "Face the Nation," October 11, 2020 - CBS News
Provider of Trump Covid drug is president's golf friend | Coronavirus | The Guardian
